These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27088215)

  • 1. D-Dimer Levels before HIV Seroconversion Remain Elevated Even after Viral Suppression and Are Associated with an Increased Risk of Non-AIDS Events.
    Freiberg MS; Bebu I; Tracy R; So-Armah K; Okulicz J; Ganesan A; Armstrong A; O'Bryan T; Rimland D; Justice AC; Agan BK;
    PLoS One; 2016; 11(4):e0152588. PubMed ID: 27088215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death.
    Boulware DR; Hullsiek KH; Puronen CE; Rupert A; Baker JV; French MA; Bohjanen PR; Novak RM; Neaton JD; Sereti I;
    J Infect Dis; 2011 Jun; 203(11):1637-46. PubMed ID: 21592994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brief Report: Racial Comparison of D-Dimer Levels in US Male Military Personnel Before and After HIV Infection and Viral Suppression.
    OʼBryan TA; Agan BK; Tracy RP; Freiberg MS; Okulicz JF; So-Armah K; Ganesan A; Rimland D; Lalani T; Deiss RG; Tramont EC
    J Acquir Immune Defic Syndr; 2018 Apr; 77(5):502-506. PubMed ID: 29315115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection.
    Baker JV; Neuhaus J; Duprez D; Kuller LH; Tracy R; Belloso WH; De Wit S; Drummond F; Lane HC; Ledergerber B; Lundgren J; Nixon DE; Paton NI; Neaton JD;
    J Acquir Immune Defic Syndr; 2011 Jan; 56(1):36-43. PubMed ID: 20930640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in D-dimer after initiation of antiretroviral therapy in adults living with HIV in Kenya.
    Teasdale CA; Hernandez C; Zerbe A; Chege D; Hawken M; El-Sadr WM
    BMC Infect Dis; 2020 Jul; 20(1):508. PubMed ID: 32664854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. d-Dimer and CRP levels are elevated prior to antiretroviral treatment in patients who develop IRIS.
    Porter BO; Ouedraogo GL; Hodge JN; Smith MA; Pau A; Roby G; Kwan R; Bishop RJ; Rehm C; Mican J; Sereti I
    Clin Immunol; 2010 Jul; 136(1):42-50. PubMed ID: 20227921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-2 cycling causes transient increases in high-sensitivity C-reactive protein and D-dimer that are not associated with plasma HIV-RNA levels.
    Porter BO; Shen J; Kovacs JA; Davey RT; Rehm C; Lozier J; Csako G; Nghiem K; Costello R; Lane HC; Sereti I
    AIDS; 2009 Sep; 23(15):2015-9. PubMed ID: 19617815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy.
    Grund B; Baker JV; Deeks SG; Wolfson J; Wentworth D; Cozzi-Lepri A; Cohen CJ; Phillips A; Lundgren JD; Neaton JD;
    PLoS One; 2016; 11(5):e0155100. PubMed ID: 27171281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
    Kuller LH; Tracy R; Belloso W; De Wit S; Drummond F; Lane HC; Ledergerber B; Lundgren J; Neuhaus J; Nixon D; Paton NI; Neaton JD;
    PLoS Med; 2008 Oct; 5(10):e203. PubMed ID: 18942885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brief Report: Changes in Levels of Inflammation After Antiretroviral Treatment During Early HIV Infection in AIDS Clinical Trials Group Study A5217.
    Macatangay BJ; Yang M; Sun X; Morton J; De Gruttola V; Little S; Hogan C; Rinaldo CR;
    J Acquir Immune Defic Syndr; 2017 May; 75(1):137-141. PubMed ID: 28198712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START study.
    Castillo-Mancilla JR; Phillips AN; Neaton JD; Neuhaus J; Sharma S; Baker JV; Collins S; Mannheimer S; Pett S; Touzeau-Römer V; Polizzotto MN; Lundgren JD; Gardner EM;
    J Int AIDS Soc; 2019 Jun; 22(6):e25297. PubMed ID: 31250552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 and D-dimer levels at seroconversion as predictors of HIV-1 disease progression.
    Hamlyn E; Fidler S; Stöhr W; Cooper DA; Tambussi G; Schechter M; Miro JM; Mcclure M; Weber J; Babiker A; Porter K;
    AIDS; 2014 Mar; 28(6):869-74. PubMed ID: 24300544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief Report: Higher ART Adherence Is Associated With Lower Systemic Inflammation in Treatment-Naive Ugandans Who Achieve Virologic Suppression.
    Castillo-Mancilla JR; Morrow M; Boum Y; Byakwaga H; Haberer JE; Martin JN; Bangsberg D; Mawhinney S; Musinguzi N; Huang Y; Tracy RP; Burdo TH; Williams K; Muzzora C; Hunt PW; Siedner MJ
    J Acquir Immune Defic Syndr; 2018 Apr; 77(5):507-513. PubMed ID: 29346185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal evaluation of markers of inflammation in HIV-positive and HIV-negative Rwandan women.
    Kiefer EM; Hoover DR; Shi Q; Dusingize JC; Sinayobye JD; Anastos K
    HIV Med; 2018 Nov; 19(10):734-744. PubMed ID: 30160347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with D-dimer levels in HIV-infected individuals.
    Borges AH; O'Connor JL; Phillips AN; Baker JV; Vjecha MJ; Losso MH; Klinker H; Lopardo G; Williams I; Lundgren JD; ; ;
    PLoS One; 2014; 9(3):e90978. PubMed ID: 24626096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-therapy inflammation and coagulation activation and long-term CD4 count responses to the initiation of antiretroviral therapy.
    Achhra AC; Phillips A; Emery S; MacArthur RD; Furrer H; De Wit S; Losso M; Law MG;
    HIV Med; 2015 Aug; 16(7):449-54. PubMed ID: 25959989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers and electrocardiographic evidence of myocardial ischemia in patients with human immunodeficiency virus infection.
    Gupta M; Miller CJ; Baker JV; Lazar J; Bogner JR; Calmy A; Soliman EZ; Neaton JD;
    Am J Cardiol; 2013 Mar; 111(5):760-4. PubMed ID: 23276469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of short-course antiretroviral therapy initiated in primary HIV-1 infection on interleukin-6 and D-dimer levels.
    Hamlyn E; Stöhr W; Cooper DA; Fisher M; Tambussi G; Schechter M; Miro JM; Vanobberghen F; Babiker A; Weber J; Mcclure M; Porter K; Fidler S;
    AIDS; 2015 Jul; 29(11):1355-61. PubMed ID: 25870986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment.
    Tenorio AR; Zheng Y; Bosch RJ; Krishnan S; Rodriguez B; Hunt PW; Plants J; Seth A; Wilson CC; Deeks SG; Lederman MM; Landay AL
    J Infect Dis; 2014 Oct; 210(8):1248-59. PubMed ID: 24795473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of Oxidative Stress to Non-AIDS Events in HIV-Infected Patients.
    Masiá M; Padilla S; Fernández M; Barber X; Moreno S; Iribarren JA; Portilla J; Peña A; Vidal F; Gutiérrez F;
    J Acquir Immune Defic Syndr; 2017 Jun; 75(2):e36-e44. PubMed ID: 28107228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.